mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.03 |